Recall Ledger

Nicotine Transdermal System Patch recall (AVEVA Drug Delivery Systems, Inc.)

DrugClass IIIOngoing

Summary: AVEVA Drug Delivery Systems, Inc. is recalling Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorpharmaceuticals.com, NDC 0536-5895-88.. Reason: Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.

What is being recalled

Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorpharmaceuticals.com, NDC 0536-5895-88.

Why

Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.

How serious is it

Class III is the least serious level: using or being exposed to this product is not likely to cause health problems, but it breaks FDA rules.

Where it was sold

Nationwide within the U.S

How to tell if yours is affected

Lot #: 56841, Expires: 03/2028

What to do

Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.

Recall facts

Recall numberD-0550-2026
CategoryDrug
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass III
StatusOngoing
Recall startedMay 14, 2026
ReportedJune 3, 2026
CompanyAVEVA Drug Delivery Systems, Inc.
Company locationMiramar, FL, United States
Initiated byVoluntary: Firm initiated
Quantity59,808 pouches (4,272 Individual Folding Carton (IFC))

More recalls from AVEVA Drug Delivery Systems, Inc. · all drug recalls · recalls from May 2026

Official FDA record